First Synthesis for Bis-Spirothiazolidine Derivatives as a Novel Heterocyclic Framework and Their Biological Activity.
Clicks: 412
ID: 61345
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
78.7
/100
412 views
279 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #5 of 22 articles by views in mini reviews in medicinal chemistry
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Spirothiazolidines were versatile synthetic scaffold processing wide spectrum of biological interests involving potential anticancer activity.Report the first synthesis of Bis Spiro-thiazolidene as a novel heterocyclic ring system.One-pot three-component reaction include condensation of p-phenyllene diamine; cyclohexanone and thioglycolic acid produced Spiro-thiazolidine 4 which undergo further condensation with cyclohexanone and thioglycolic acid with eqiumolar ratio to introduce Bis-Spiothiazolidine 5 as a first synthesis. Also;bis spiro-thiazolidine arylidene derivatives 6‒13 were synthesized by reaction of Bis-Spiothiazolidine 5 with different aromatic benzaldehyde.Four compounds 13, 12, 9 and 11 have showed high significantly anticancer activity compared to Doxorubicin® (positive control) against Human liver carcinoma (HepG2) and human normal Retina pigmented epithelium (RPE-1) cell lines.The novel bis-spirothiazolidine deriviatives synthesized for the first time and showed excellent anticancer activities.
| Reference Key |
flefel2019firstmini
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Flefel, Eman M;Sofany, Walaa I;Awad, Hanem M;Shahat, Mahmoud El-; |
| Journal | mini reviews in medicinal chemistry |
| Year | 2019 |
| DOI |
10.2174/1389557519666190920114852
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.